-
A divided Congress gave final passage to Democrats’ flagship climate and health care bill.
-
President Biden is urging swift House passage, and the House seems on track to provide final congressional approval when it returns briefly from summer recess on Friday.
-
West Virginia Sen. Joe Manchin reached an agreement with Senate Majority Leader Chuck Schumer that had eluded them for months on health care costs, energy and climate issues.
-
The governor's order requires state agencies to review contracts with pharmacy benefit managers to ensure that costs are justified. He also expressed disappointment over the FDA's delay in approving Canadian drug imports.
-
A local chapter of the Alliance for Retired Americans wants Sens. Rick Scott and Marco Rubio to support legislation that would decrease health care and prescription drug costs for seniors.
-
Perspective: Amid skyrocketing drug prices, it’s understandable that patients desperately need help affording medicine, especially when their health is on the line. But these programs create a mirage that perpetuates our health care system’s reckless spending.
-
A diabetes diagnosis is not always related to a person’s weight or overall health, especially for those with Type 1 diabetes, who are dependent on insulin treatment for life.
-
The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for COVID. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
-
The number of pharmacies dispensing 340B discounted drugs soared to more than 31,000 this year. Drugmakers struck back by halting some discounts. Hospitals say they are losing millions of dollars — and cutting back services to patients — as a result.
-
Democrats agreed to a significant — but slimmed down — proposal to help lower prescription drug prices, bringing aboard notable holdouts on the measure, including Arizona Sen. Kyrsten Sinema.